Author(s):
Kusworini Handono, Nanda Rachmad Putra Gofur, Nurdiana, Handono Kalim, Cesarius Singgih Wahono, Sri Poeranto
Email(s):
dr.kusworini@gmail.com
DOI:
10.5958/0974-360X.2020.00954.3 
Address:
Kusworini Handono1, Nanda Rachmad Putra Gofur2, Nurdiana3, Handono Kalim4, Cesarius Singgih Wahono4, Sri Poeranto5
1Dept of Pathology Clinic, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.
2Doctoral Program of Medical Science, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.
3Dept of Pharmacology, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.
4Dept of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.
5Dept of Parasitology Clinic, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.
*Corresponding Author
Published In:
Volume - 13,
Issue - 11,
Year - 2020
ABSTRACT:
Introduction: Systemic Lupus Erythematosus (SLE) condition have hyperactivity immune which causes decreasing immune ability to fight bacteria, resulting susceptible to infection. Believed that one clinical manifestation in oral cavity is gingivitis. Discovery of gingivitis in SLE patients supports proving that there is an increased risk of infection and inflammation, which is associated with autoimmune disease. Objective of this study is to determine gingivitis and its severity in SLE patients. Methods: A total of 61 SLE patients were recruited in the study in Rheumatology Department Dr. Saiful Anwar Hospital, Malang. Characteristics data as disease duration and treatment duration were recorded. Clinical parameters as Systemic Lupus Erythematosus Activity Index (SLEDAI), gingival index, bleeding on probing were recorded and blood serum were collected for anti-double stranded deoxyribonucleic acid (anti-dsDNA) antibody levels in all groups. Anti-dsDNA levels were calculated using Enzyme-Linked Immune-Sorbent Assay (ELISA). Results: SLE patients with normal gingiva was 3 patients (4.91%) with mean gingival index 0, 11 patients (18.03%) was mild inflammation with mean gingival index 0.36±0.13, 17 patients (27.86%) was moderate inflammation with mean gingival index 1.85 ±0.18, and 30 patients (49.18%) was severe inflammation with mean gingival index 2.78±0.28. There was a significant correlation between gingivitis with SLE severity, anti-dsDNA levels, and BOP on SLE patients (p<0.001). No correlation found between gingivitis with disease duration, and treatment duration. Conclusion: Gingivitis is one of clinical manifestation of SLE. Gingival inflammation related to SLE severity, anti-dsDNA levels and bleeding on probing finding.
Cite this article:
Kusworini Handono, Nanda Rachmad Putra Gofur, Nurdiana, Handono Kalim, Cesarius Singgih Wahono, Sri Poeranto. Gingivitis on Systemic Lupus Erythematosus (SLE) patients: A Pilot study. Research J. Pharm. and Tech. 2020; 13(11):5466-5470. doi: 10.5958/0974-360X.2020.00954.3
Cite(Electronic):
Kusworini Handono, Nanda Rachmad Putra Gofur, Nurdiana, Handono Kalim, Cesarius Singgih Wahono, Sri Poeranto. Gingivitis on Systemic Lupus Erythematosus (SLE) patients: A Pilot study. Research J. Pharm. and Tech. 2020; 13(11):5466-5470. doi: 10.5958/0974-360X.2020.00954.3 Available on: https://rjptonline.org/AbstractView.aspx?PID=2020-13-11-69
REFERENCES:
1. Diah, Widodorini, T., Nugreheni, N.E. Perbedaan Angka Kejadian Gingivitis antara Usia Pra-Pubertas dan Pubertas di Kota. E-Prodenta Journal of Dentistry. 2(1); 2018:108-115.
2. Lindhe, J., Lang, N.P and Karring, T. Clinical Periodontology and Implant Dentistry: Volume 2. 5th edition. Blackwell Publishing, Oxford. 2008.
3. Agrali, O.B., Kuru, B.E. Periodontal treatment in a generalized severe chronic periodontitis patient: A case report with 7-year follow-up. European journal of dentistry. 9(2); 2015:288-92.
4. Lang, N.P., and Bartold, P.M. Periodontal health. Journal of Clinical Periodontology. 45; 2018:S9–S16.doi:10.1111/jcpe.12936
5. Nazir, M. A. Prevalence of periodontal disease, its association with systemic diseases and prevention. International Journal of Health Sciences. 1(2); 2017:72–80. doi: 10.1109/ISIP.2008.139.
6. Novak, M.J., Novak, K.F. Chronic Periodontitis, in: Newman, M.G., Takei, H., Klokkevoid, P.R., Carranza, F.A. (Eds.), Carranza’s Clinical Periodontology. Saunders Elsevier, Missouri 2012; 11thed: pp. 160-164, 320-323.
7. Hajishengallis, G. Aging and its Impact on Innate Immunity and Inflammation: Implications for Periodontitis. J Oral Biosci. 56(1); 2014:30–37. doi:10.1016/j.job.2013.09.001.
8. Isenberg, D.A., Manson, J.J and Ehrenstein, M.R. Fifty years of anti-dsDNA antibodies: are we approaching journey’s end? Rheumatology. 46(7); 2007:1052-1056.
9. Rutter-Locher Z, et al. Periodontal disease and autoimmunity: What we have learned from microbiome studies in rheumatology. In: Arjunan P, eds. Periodontitis – A Useful Reference. J Intech Open 69(12): 2017:113-141 [online] available at: http://dx.doi.org/10.5772/intechopen.69012
10. Beltrán-Aguilar, E.D et al. Recording and surveillance systems for periodontal diseases. Periodontology 2000. 60(1); 2012: 40-53.
11. Etchegaray-Morales I, et al. Factors Associated with Health-Related Quality of Life in Mexican Lupus Patients Using the Lupus Qol. PLoS ONE. 12(1); 2017: e0170209. doi:10.1371/journal.pone.0170209
12. Gan, SD and Patel, KR. Enzyme Immunoassay and Enzyme-Linked Immunosorbent Assay. Journal Invest Dermatol. 133(12), 2013: 54-59. doi: 10.1038/jid.2013.287
13. Mukaka, M. A guide to appropriate use of Correlation coefficient in medical research. Malawi Medical Journal: The Journal of Medical Association of Malawi. 24(3); 2012: 69–71.
14. Salama R, et al. Cellular senescence and its effector programs. Genes and Development. 28; 2014:99-114.
15. Kaur, G., Mohindra, K., Singla, S. Autoimmunity – Basics and link with periodontal disease. Autoimmunity Reviews. 16(1); 2017:64-71.
16. Saleh, A.M., Kurniati, N and Syarif, BH. Assesment of Systemic Lupus Erytematous using SLEDAI Score in Pediatric Department RSCM Jakarta Indonesia. Sari Pediatri. 16(4); 2016: 292-298.
17. Bertsias, G., Cervera, R., Boumpas, D.T., Systemic Lupus Erythematosus: Pathogenesis and Clinical Features. Eular On-line Course on Rheumatic Diseases. 4(1); 2012:476–505.
18. Giles, B.M., Boackle, S.A. Linking complement and anti-dsDNA antibodies in the pathogenesis of systemic lupus erythematosus. Immunologic Research. 55(1–3); 2013: 10–21.
19. Kavanaugh, A., et al. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. Arch Pathol Lab Med. 124(1); 2000: 71–81.
20. Wallace, D.J. The Lupus Book: A Guide For Patients and Their Families. 5th ed. Oxford University Press, New York.2012.
21. Bhat K, et al. Synthesis of Some Novel Flavanones and Evaluation of Antioxidant Activities. Research Journal of Pharmacy and Technology. 12(5); 2019:2109-2115.
22. Bhat K, et al. The Use of Bone Tissue Non-Steroid Anabolizators in Treatment of Osteoporosis. Research Journal of Pharmacy and Technology. 12(5); 2019:2195-2199